RecruitingNCT06548269

Multimodal Prognostic Assessment of Acute Ischemic Stroke Patients With Atrial Fibrillation: a Prospective, Multicenter, Observational Study (IAT-CLOSURE)


Sponsor

Jinan Central Hospital

Enrollment

1,000 participants

Start Date

Nov 15, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The main purpose of this study is to investigate the safety and outcomes of different treatment strategies, including best medical therapy (OAC \[oral anticoagulation\], antiplatelet \[APT\]) and left atrial appendage closure \[LAAC\] in acute ischemic stroke (AIS) patients with atrial fibrillation (AF) based on multimodal assessment from combined brain and cardiologic work-up, and to optimize secondary prevention.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This observational study is tracking patients who had an ischemic stroke (a stroke caused by a blood clot) and also have atrial fibrillation (an irregular heartbeat). Researchers want to better understand the long-term risks these patients face — particularly the risk of the stroke coming back — and whether closing a small pouch in the heart called the left atrial appendage might help prevent future strokes. No experimental treatment is involved; the study collects data and follows patients over time. **You may be eligible if...** - You are over 18 years old - You had an ischemic stroke within the past 14 days - You have been diagnosed with atrial fibrillation (either before or during this hospitalization) - You or your legal representative are able to provide informed consent **You may NOT be eligible if...** - You have a pacemaker, defibrillator, or cardiac monitor implanted - The left atrial appendage has already been removed or blocked - Your atrial fibrillation is caused by a temporary reversible condition - You are pregnant or breastfeeding - You are unable to attend follow-up visits (e.g., no fixed address, living overseas) - You have a life expectancy of less than 1 year Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTCardiologic work-up

Noninvasive prolonged ECG monitoring with a duration of 7 days measuring AF burden; Echocardiography measuring LA volume or volume index, LA diameter or diameter index; Cardiac CTA measuring LAA morphologies, cardiac thrombus.


Locations(1)

Jinan Central Hospital

Jinan, Shandong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06548269


Related Trials